. . . greener synthetic pathways . . .
| By Chemical Engineering
Merck (see item above) received the Greener Synthetic Pathways Award for discovering a catalytic synthesis for sitagliptin (a chiral β-amino acid derivative), an active ingredient for the company’s new treatment for type 2 diabetes, Junuvia.…